Streptococcus pneumoniae: distribución de serotipos, sensibilidad antibiótica, factores de riesgo y mortalidad en Galicia en un periodo de 2 años

Musher, 2010, Streptococcus pneumonia 2010, Streptococcus pneumoniae Picazo, 2013, Consenso sobre la vacunación anti-neumocócica en el adulto con patología de base, Rev Esp Quimioter., 26, 232 Pérez-Rodríguez, 2014, Influencia de la edad en la enfermedad neumocócica invasiva y en la resistencia a antimicrobianos, Med Clin (Barc)., 143, 287, 10.1016/j.medcli.2013.07.023 Hausdorff, 2005, Epidemiological differences among pneumococcal serotypes, Lancet Infect Dis., 5, 83, 10.1016/S1473-3099(05)70083-9 Hausdorff, 2001, Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children, Lancet., 357, 950, 10.1016/S0140-6736(00)04222-7 Harboe, 2010, Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades, Clin Infect Dis., 50, 329, 10.1086/649872 Luján, 2013, Effects of immunocompromise and comorbidities on pneumococcal serotypes causing invasive respiratory infection in adults: Implications for vaccine strategies, Clin Infect Dis., 57, 1722, 10.1093/cid/cit640 Rodríguez, 2011, Invasive pneumococcal disease: Association between serotype, clinical presentation and lethality, Vaccine., 29, 5740, 10.1016/j.vaccine.2011.05.099 Van Hoek, 2012, The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England, J Infect., 65, 17, 10.1016/j.jinf.2012.02.017 Plosker, 2013, 13-valent pneumococcal conjugate vaccine: A review of its use in infants, children, and adolescents, Paediatr Drugs, 15, 403, 10.1007/s40272-013-0047-z Dirección de Innovación e Xestión da Saúde Publica, Dirección de Asistencia Sanitaria. Vacunación frente al neumococo. Estudio piloto. Instrucción [monografía de internet]. Santiago de Compostela: Dirección de Innovación e Xestión da Saúde Publica, Dirección de Asistencia Sanitaria. Consellería de Sanidade; 2010 [consultado 14 Nov 2013]. Disponible en: http://www.sergas.es/cas/DocumentacionTecnica/docs/SaudePublica/vacunas/instruccion%20neumococo_castellano.pdf Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Twenty-Fourth Informational Supplement. CLSI document M100-S24. 2014. Slotveb, 2004, Simple, rapid latex agglutination test for serotyping of pneumococci (Pneumotest-Latex), J Clin Microbiol., 42, 2518, 10.1128/JCM.42.6.2518-2522.2004 Austrian, 1976, The quellung reaction, a neglected microbiologic technique, Mt Sinai J Med., 43, 699 Dagan, 1996, Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine, J Infect Dis., 174, 1271, 10.1093/infdis/174.6.1271 Whitney, 2003, Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine, N Engl J Med., 348, 1737, 10.1056/NEJMoa022823 Ardanuy, 2009, Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007, Clin Infect Dis., 48, 57, 10.1086/594125 Ardanuy, 2012, Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): Implications for future vaccination strategies, PLoS ONE, 7, e43619, 10.1371/journal.pone.0043619 Richter, 2013, Pneumococcal serotypes before and after Introduction of Conjugate Vaccines, United States, 1999-2011, Emerg Infect Dis., 19, 1074, 10.3201/eid1907.121830 Demczuk, 2013, Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012, Can J Microbiol., 59, 778, 10.1139/cjm-2013-0614 Cooper, 2011, The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A, Vaccine., 29, 7207, 10.1016/j.vaccine.2011.06.056 Liñares, 2010, Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period, Clin Microbiol Infect., 16, 402, 10.1111/j.1469-0691.2010.03182.x Trotter, 2010, Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006, J Infect., 60, 200, 10.1016/j.jinf.2009.12.008 Cercenado E, Cantón R, editores. Detección fenotípica de mecanismos de resistencia en grampositivos. [monografía de internet]. 2011. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica; 2011 [consultado 14 Nov 2013]. Disponible en: http://www.seimc.org/contenidos/documentoscientificos/procedimientosmicrobiologia/seimc-procedimientomicrobiologia39.pdf Green, 2011, Increase in prevalence of Streptococcus pneumoniae serotype 6C at eight Children's Hospitals in the United States from 1993 to 2009, J Clin Microbiol., 49, 2097, 10.1128/JCM.02207-10 Rolo, 2011, Trends of invasive serotype 6C pneumococci in Spain: Emergence of a new lineage, J Antimicrob Chemother., 66, 1712, 10.1093/jac/dkr193 Rock, 2013, Epidemiology of invasive pneumococcal disease and vaccine provision in a tertiary referral center, Europ J Clin Microbiol Infect Dis., 32, 1135, 10.1007/s10096-013-1859-z Weinberger, 2010, Association of serotype with risk of death due to pneumococcal pneumonia: A meta-analysis, Clin Infect Dis., 51, 692, 10.1086/655828 Pletz, 2010, The paradox in pneumococcal serotypes: Highly invasive does not mean highly lethal, Eur Respir J., 36, 712, 10.1183/09031936.00041210